PALI
#3239
Palisade Bio, Inc. - Common Stock
2.0 4 USD
-0.02%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.92%
Variación mensual
+16.57%
Variación en los últimos 6 meses
+20.00%
Cambio anual
+20.00%
Cierres anteriores
2.0 8
Open
1.9 9
Mínimo
1.9 9
High
2.0 6
Volumen
1 330
Financials
- Market Capitalization 354.1 M
- Employee 14
- Founded 2005
- CEO N/A
- Website www.palisadebio.com
- Headquarter Delaware, United States
- FIGI BBG000QG4DJ2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3223 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 15.41 USD | -3.14% | +18.81% | +23.28% | -36.30% | 359.58 M USD | ||
| 3233 |  IMRX Immuneering Corporation - Class A Common Stock | 5.53 USD | +8.43% | +9.50% | +39.29% | +36.21% | 357.78 M USD | ||
| 3240 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 4.87 USD | +1.88% | +11.70% | +36.03% | +283.46% | 346.68 M USD | ||
| 3250 |  OABI OmniAb, Inc. - Common Stock | 2.31 USD | -0.43% | -3.35% | 0.00% | +10.53% | 334.89 M USD |